Documents déclassifiés de Pfizer et revelations choc de Christine Cotton

Sud Radio · Dailymotion · Watch ▶

📅 2022-05-13🎙️ André Bercoff (host)📺 Sud Radio⏱ 15 min
“Look at real life and stop watching TV, friends. We have hundreds of thousands of adverse events, 25% serious, hitting young people lost in unbelievable medical wandering — 40 trips to the ER without a diagnosis. Lawyers have filed a poisoning complaint.”

Key statements

  • The December 2020 Emergency Use Authorization was based on an interim analysis covering only 3 of the planned 24 months — with half of participants followed less than 2 months. Medium- and long-term tolerance could not be evaluated. ▶ 01:47
    Sources: Pfizer C4591001 interim clinical study report (Dec 2020)
  • Statistically, no efficacy on severe cases, no efficacy in the over-75s. In adolescents and children, also no demonstrated efficacy on severe forms. The 95% rests on a biased primary endpoint. ▶ 03:19
    Sources: Pfizer C4591001 interim clinical study report (Dec 2020)
  • No measurement of neutralizing antibodies at two months post-dose 2 — even though the monkey study and Phase 1-2 data already showed antibody decline from two months out. The omission masked waning protection. ▶ 03:49
    Sources: Pfizer C4591001 Protocol (immunogenicity schedule); Pfizer monkey preclinical study; Pfizer Phase 1-2 results
  • WHO guidance at the time called for six months of follow-up to assess tolerance and one year for efficacy. The three-month interim analysis contravened those prior directives — calling for a halt and an independent audit. ▶ 04:15
    Sources: WHO guidelines on COVID-19 vaccine evaluation (pre-2020)
  • Pfizer's own CEO has acknowledged antibodies decline. A third dose was rolled out, a fourth is in progress, a fifth is arriving in the United States — vaccines do not prevent infection or transmission. The "prevents severe forms" claim rests on real-world studies with questionable methodology. ▶ 04:41
    Sources: Pfizer press statements (Albert Bourla, 2021-2022)
  • Reviewing a Ventavia patient case-report form (PDF) from the released documents, Cotton found a masked COVID date for a patient who apparently died from COVID — indicating non-transparent data handling. ▶ 06:30
    Sources: Pfizer C4591001 case-report forms (court-released, Ventavia site)
  • An Australian biostatistician ("Jikky" / Jikkyleaks) examined the court-released SAS tables and surfaced patient IDs starting with "4444" — outside the CDISC numbering norm. The "4444" block belongs to site 1231, an Argentine military hospital that recruited 5,700+ of the trial's ~44,000 patients between mid-August and end-September 2020. ▶ 09:33
    Sources: Pfizer C4591001 SAS datasets (court-released); CDISC standards
  • Real-world: hundreds of thousands of adverse events with 25% serious — hitting young people now lost in months of medical wandering, sometimes 40 ER visits with no diagnosis, told their symptoms are "all in your head." ▶ 13:49
    Sources: EudraVigilance database; VAERS database
  • Lawyers have taken up the case: a French Senate inquiry into adverse events (where Cotton testified) is under way, and a criminal complaint for "poisoning" by these vaccines has been filed. ▶ 14:34
    Sources: French Senate OPECST inquiry on adverse events; Criminal complaint for poisoning (France)

Documents cited

  • Pfizer C4591001 Protocol — NEJM supplementary materials
  • Pfizer C4591001 interim clinical study report (December 2020) — FDA briefing documents, Dec 2020 VRBPAC
  • Pfizer C4591001 case-report forms and SAS datasets (court-released) — PHMPT v. FDA litigation
  • Pfizer monkey preclinical study & Phase 1-2 results — Cited in EMA EPAR and peer-reviewed publications (Walsh et al., NEJM 2020)
  • WHO guidelines on COVID-19 vaccine evaluation (pre-2020) — WHO
  • EudraVigilance / VAERS adverse-event databases — EMA / CDC-FDA
  • French Senate OPECST inquiry on COVID-19 vaccine adverse events — Sénat

Research follow-ups